Day 3: Top Takeaways From ASCO24
Suivant
<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Dr. Linda Duska and Dr. Kathleen Moore discuss key studies in the evolving controversy over radical upfront surgery versus neoadjuvant chemotherapy in advanced ovarian cancer.</span> <span style= ...
Épisodes Recommandés
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. We’re back with another interview from this year’s IASLC conference. This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mar ...
Background Large trials up to this point had established the role of thr ...